Align Technology Inc. (ALGN): Today's Featured Health Services Laggard

Align Technology ( ALGN) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.9%. By the end of trading, Align Technology fell $0.50 (-1.3%) to $38.70 on light volume. Throughout the day, 530,754 shares of Align Technology exchanged hands as compared to its average daily volume of 918,600 shares. The stock ranged in price between $38.69-$39.30 after having opened the day at $39.11 as compared to the previous trading day's close of $39.20. Other companies within the Health Services industry that declined today were: Mazor Robotics ( MZOR), down 8.5%, BSD Medical Corporation ( BSDM), down 6.8%, CardioNet ( BEAT), down 5.5% and Hooper Holmes ( HH), down 4.4%.

Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. Align Technology has a market cap of $3.2 billion and is part of the health care sector. Shares are up 42.0% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Align Technology a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Align Technology as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.

On the positive front, ImmunoCellular Therapeutics ( IMUC), up 15.1%, Organovo Holdings ( ONVO), up 13.3%, Given Imaging ( GIVN), up 10.3% and China Cord Blood ( CO), up 9.7% , were all gainers within the health services industry with Stryker Corporation ( SYK) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Bears Are Looming Over Amazon: Cramer's 'Mad Money' Recap (Wed 8/23/17)

Jack Dorsey's Odd Couple Win Big; Estee Lauder's Stunning Quarter: Jim Cramer's Best Blog

Cramer: Estee Lauder Puts a (Selfie-Ready) Face on a Stunning Quarter

Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More